Replies to post #711778 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

They’ve done > 1,000 compassionate vaccines to patients in the UK since 2014 so manual production is not a concern for the first 1,200 vaccines based of company’s forecast at the beginning after approval.

In the last 3 years that has brought in $4,618M revenue (total revenue) on a COGS of $35,904M (the payments made to Advent specifically for mfg and running specials, not SOWs and such).

Not sure if NWBO could raise enough cash to run such a program.

Not that it matters. The MAA submission is just fish bait for retail.